Lotto Theopista, Gallay Joanna, Zuakulu Martin, Ternon Beatrice, Decosterd Laurent Arthur, Kulinkina Alexandra V, Genton Blaise
Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.
Department of Public Health, University of Basel, 4001 Basel, Switzerland.
Antibiotics (Basel). 2025 Feb 13;14(2):193. doi: 10.3390/antibiotics14020193.
Inappropriate antibiotic use drives antimicrobial resistance and remains a global concern. Evidence suggests antibiotic use may be higher among malaria-negative patients compared to malaria-positive ones, but uncertainty persists, particularly in regions with varying malaria prevalence. This study measured antibiotic residuals in three Tanzanian regions with varying malaria epidemiology and analyzed factors influencing their presence.
A cross-sectional household survey was conducted in 2015, covering a population of 6000 individuals across three regions of Tanzania. Dried blood spot samples from a subset of participants were analyzed using broad-range tandem mass spectrometry to detect residual antibiotics. Risk factors associated with antibiotic presence, including household healthcare-seeking behaviors, malaria testing, and other relevant variables, were evaluated.
The overall prevalence of residual antibiotics in the study population was 14.4% (438/3036; 95% CI: 11.4-15.8%). Stratified by malaria transmission intensity, antibiotic prevalence was 17.2% (95% CI: 12.9-17.2%) in Mwanza (low), 14.6% (95% CI: 10.6-15.0%) in Mbeya (moderate), and 11.2% (95% CI: 7.9-11.6%) in Mtwara (high). Trimethoprim was the most frequently detected antibiotic (6.1%), followed by sulfamethoxazole (4.4%) and penicillin V (0.001%).
Residual antibiotic prevalence did not directly correlate with malaria endemicity but was influenced by healthcare practices, including co-prescription of antibiotics and antimalarials. The higher antibiotic use in malaria-negative cases highlights the need for improved diagnostics to reduce unnecessary use and mitigate antimicrobial resistance in malaria-endemic areas.
抗生素使用不当会导致抗菌药物耐药性,仍是全球关注的问题。有证据表明,与疟疾阳性患者相比,疟疾阴性患者的抗生素使用可能更高,但仍存在不确定性,尤其是在疟疾流行程度不同的地区。本研究测量了坦桑尼亚三个疟疾流行病学情况不同的地区的抗生素残留情况,并分析了影响其存在的因素。
2015年进行了一项横断面家庭调查,覆盖坦桑尼亚三个地区的6000人。使用宽范围串联质谱法分析了一部分参与者的干血斑样本,以检测残留抗生素。评估了与抗生素存在相关的风险因素,包括家庭寻求医疗行为、疟疾检测及其他相关变量。
研究人群中残留抗生素的总体患病率为14.4%(438/3036;95%置信区间:11.4-15.8%)。按疟疾传播强度分层,姆万扎(低传播强度)的抗生素患病率为17.2%(95%置信区间:12.9-17.2%),姆贝亚(中等传播强度)为14.6%(95%置信区间:10.6-15.0%),姆特瓦拉(高传播强度)为11.2%(95%置信区间:7.9-11.6%)。甲氧苄啶是最常检测到的抗生素(6.1%),其次是磺胺甲恶唑(4.4%)和青霉素V(0.001%)。
残留抗生素患病率与疟疾流行程度没有直接关联,但受到医疗实践的影响,包括抗生素和抗疟药的联合处方。疟疾阴性病例中较高的抗生素使用凸显了改进诊断以减少不必要使用并减轻疟疾流行地区抗菌药物耐药性的必要性。